Guest Editorial Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology February 28, 2025Vol.51 No.08By Harpreet Singh
Guest Editorial The fight against cancer is global. Our focus must be as well. February 21, 2025Vol.51 No.07By W. Kimryn Rathmell
Guest Editorial As cancer research is threatened, we must engage in political advocacy February 21, 2025Vol.51 No.07By George J. Weiner
FreeGuest Editorial Preparing to take care of each other in ways we never imagined February 14, 2025Vol.51 No.06By W. Kimryn Rathmell
Guest Editorial From the chairs of ECOG-ACRIN: A perspective on indirect costs February 14, 2025Vol.51 No.06By Peter J. O'Dwyer and Mitchell D. Schnall
Guest Editorial Communication—We need more, not less February 07, 2025Vol.51 No.05By W. Kimryn Rathmell
Guest Editorial World Cancer Day 2025: A symbol of personal and collective uncertainty February 07, 2025Vol.51 No.05By Ruth Fein Revell
Guest Editorial Our challenge: To find zen in chaos January 31, 2025Vol.51 No.04By W. Kimryn Rathmell
Guest Editorial Foundations acquire a critical new role as federal funding for cancer research falters January 31, 2025Vol.51 No.04By Ryan Schoenfeld and Raymond N. DuBois
